z-logo
open-access-imgOpen Access
Coverage of diarrhoea‐associated E scherichia coli isolates from different origins with two types of phage cocktails
Author(s) -
Bourdin Gilles,
Navarro Armando,
Sarker Shafiqul A.,
Pittet AnneC.,
Qadri Firdausi,
Sultana Shamima,
Cravioto Alejandro,
Talukder Kaisar A.,
Reuteler Gloria,
Brüssow Harald
Publication year - 2014
Publication title -
microbial biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.287
H-Index - 74
ISSN - 1751-7915
DOI - 10.1111/1751-7915.12113
Subject(s) - serotype , phage typing , microbiology and biotechnology , biology , escherichia coli , vtec , virology , genetics , gene
Summary Eighty‐nine T 4‐like phages from our phage collection were tested against four collections of childhood diarrhoea‐associated E scherichia coli isolates representing different geographical origins ( M exico versus   B angladesh), serotypes (69 O , 27 H serotypes), pathotypes ( ETEC , EPEC , EIEC , EAEC , VTEC , S higella ), epidemiological settings (community and hospitalized diarrhoea) and years of isolation. With a cocktail consisting of 3 to 14 T 4‐like phages, we achieved 54% to 69% coverage against predominantly EPEC isolates from M exico, 30% to 53% against mostly ETEC isolates from a prospective survey in B angladesh, 24% to 61% against a mixture of pathotypes isolated from hospitalized children in B angladesh, and 60% coverage against S higella isolates. In comparison a commercial R ussian phage cocktail containing a complex mixture of many different genera of coliphages showed 19%, 33%, 50% and 90% coverage, respectively, against the four above‐mentioned collections. Few O serotype‐specific phages and no broad‐host range phages were detected in our T 4‐like phage collection. Interference phenomena between the phage isolates were observed when constituting larger phage cocktails. Since the coverage of a given T 4‐like phage cocktail differed with geographical area and epidemiological setting, a phage composition adapted to a local situation is needed for phage therapy approaches against E . coli pathogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom